Crossmark

Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1007/s00125-022-05715-4

Published Online: 2022-05-17

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Karagiannis, Thomas https://orcid.org/0000-0001-5242-0574
Avgerinos, Ioannis https://orcid.org/0000-0003-2232-1342
Liakos, Aris https://orcid.org/0000-0003-3261-2979
Del Prato, Stefano https://orcid.org/0000-0002-5388-0270
Matthews, David R. https://orcid.org/0000-0001-6504-0036
Tsapas, Apostolos https://orcid.org/0000-0003-0221-4072
Bekiari, Eleni https://orcid.org/0000-0001-9975-3835
License Information

Text and Data Mining valid from 2022-05-17

Version of Record valid from 2022-05-17
More Information

Article History

Received: 10 December 2021

Accepted: 21 February 2022

First Online: 17 May 2022